Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

A patient's grey hair regained color during treatment with adalimumab.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.